Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
GPI-1046
Hello, I am very interested in finding out more information on the current status of the research being done with GPI-1046 by Guilford Pharmaceuticals of Baltimore, Maryland and Amgen. Does anyone know of someone who may be involved in the clinical trials for this drug? The trials on human subjects were scheduled to start the latter part of this year. Thank you, Rick Hansen
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance